Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company’s principal business lines are focused on the production, distribution and sale of cannabis and cannabis-derivative products in Canada and internationally, and the propagation of vegetables and ornamental plants in North America. Its segments include Canadian Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. It also has a controlling interest in Bevo Farms Ltd., North America's supplier of propagated vegetables and ornamental plants in North America. Its subsidiaries include Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, TerraFarma Inc., Whistler Medical Marijuana Corporation, and Indica Industries Pty Ltd., among others.


TSX:ACB - Post by User

Bullboard Posts
Comment by Heikogson Apr 03, 2019 12:14am
136 Views
Post# 29574041

RE:RE:Does this mean...

RE:RE:Does this mean...Ok that worked well, now let me add the info now that I got your attention, lol.

Advantages of a Shelf Prospectus

  • Quick access to markets: Generally one week from deal terms announced to closing and cash in the bank.
  • Flexibility: In addition to ordinary equity, units, warrants and debt securities may be offered under the base shelf prospects.
  • Certainty: Prospectus supplements are not generally reviewed by securities commissions.  Many financings have been interrupted and, in some cases, derailed by securities commission review of the offering company’s technical reports.  Filing a base shelf prospectus ensures that the technical reports are not reviewed each time the market is accessed.
  • Less cost: Once a base shelf prospectus has been filed, accessing the capital markets requires only finalization of a prospectus supplement – a much less complex document than even a short form prospectus. This results in lower future financing costs for the issuer.
  • Attractiveness to Agents/Underwriters: The ability to close a shelf prospectus financing quickly means less market risk for agents and underwriters, making it more likely they will agree to assist with a financing at any given time.
  • Security: Once filed, a base shelf prospectus is valid for 25 months and permits ongoing financing from time to time of up to the dollar amount stated in the prospectus.
  • Marketing: After a receipt has been issued for a base shelf prospectus, securities regulators do not have the same regulatory concerns about “marketing” before the filing of a shelf prospectus supplement as they do about “pre-marketing” before the filing of a short form prospectus or a long form prospectus.


Market Perception

There has been a perception that filing a shelf prospectus will signal imminent financing and create a market overhang.   Our experience is that negative market reaction, if any, is temporary.  

Bullboard Posts